LKTN Cracks Down on Unlicensed Tobacco Retailers in Malaysia

Regulations by 2FIRSTS.ai

Aug.21.2024

LKTN Cracks Down on Unlicensed Tobacco Retailers in Malaysia

LKTN Chairman Datuk Wan Abd Rahim Wan Abdullah stated at a parade event today that Malaysia has issued 30,000 tobacco licenses nationwide, with 3,000 in Kelantan.

According to The Sun, on August 21, Datuk Wan Abd Rahim Wan Abdullah, chairman of Malaysia's National Kenaf and Tobacco Board (LKTN), announced at the "Jalur Gemilang" and Independence Day parade ceremony today that 30,000 tobacco distribution or production licenses have been registered and issued nationwide, with approximately 3,000 licenses approved in the state of Kelantan.

He pointed out that many warehouse owners, retailers, and distributors in rural areas have not yet applied for tobacco distribution or production licenses.

To address this issue and increase the license application rate, LKTN has implemented intelligent enforcement measures. These measures include conducting on-site inspections in key urban and rural areas to enhance understanding of license requirements.

We have identified several non-compliant business establishments, including retailers, which may face fines of up to RM 250,000 (USD 57,084) for selling and distributing tobacco products without proper authorization.

Media reports earlier indicated that from January 1, 2023, to July 15 of the same year, LKTN has approved 29,098 tobacco distribution or production licenses out of 38,067 registered establishments on the Malaysian peninsula.

According to reports, the Malaysia National Tobacco Board, established in 1973, was dissolved in 2010 and replaced by the National Kenaf and Tobacco Board (LKTN). The board's purpose is to regulate and coordinate activities related to the tobacco industry in Malaysia.

References:

[1] LKTN urges those involved in tobacco production, distribution to apply for licences

Also Read:

[1] Malaysia Health Minister: Smoking Control Act 2024 to Be Implemented in October

[2] Malaysia Health Department Cracks Down on Underage E-Cigarette Sales

[3] Concerns over Impact of Proposed Tobacco Control Act on E-Cigarettes

[4] Malaysia to Implement Public Health Tobacco Control Act by 2024

[5] Male Student Hospitalized After Overdosing on E-Liquid with Psychedelic Ingredient

[6] Malaysian Government Plans to Regulate E-Cigarette Sales among Youth

[7] Malaysia to Soon Implement Ban on E-Cigarette Sales: Report

#Traditional tobacco #Asia #Regulation #Malaysia

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

Singapore media: Relx-linked firm Hellow SG struck off and office closed in Singapore

According to The Straits Times, after Singapore strengthened anti-vaping enforcement from September 2025, Relx International-linked entity Hellow SG voluntarily applied for deregistration and was officially struck off by ACRA on September 30, closing its local office. The company reportedly undertook regional business support and operated quietly.

Nov.03 by 2FIRSTS.ai

62.5% of Vapers Still Use Disposables; 82% for Ages 25–34, Survey Finds

Vape retailer Haypp reports that 62.5% of vapers still use disposable vapes, rising to 82% among those aged 25–34. 35% of disposable users say they are still buying disposables. Black-market purchases reportedly come mainly from local smaller shops (55%) and specialist vape stores (37%), as well as supermarkets, online retailers and car boot sales. 78.5% of respondents are using pre-ban stock, posing safety risks from aging lithium-ion batteries; 14% plan to continue buying disposables,.

Oct.23 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.